Last Update Time:
04-Mar-2025 10:04:16
ISIN:
INE052I01032
Sector:
Chemicals
Symbol:
CAMLINFINE
Camlin Fine Sciences Limited
₹151.31
₹7.17
(4.97%)
▲
Prev. Close
₹144.14
Open
₹143.00
Close
₹0.00
Range
₹143.74 - ₹158.88
High
₹151.57
Low
₹143.00
Ind. Close
₹0.00
VWAP
₹148.04
The current stock price of Camlin Fine Sciences Limited is ₹151.31, with a target price range between ₹143.74 and ₹158.88. The stock has experienced a price change of ₹7.17 (4.97%), reflecting recent market volatility.
Today's opening price was ₹143.00, while the previous close stood at ₹144.14.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Camlin Fine Sciences Limited Price Chart
Camlin Fine Sciences Limited Pre Open Market Overview: 04-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 143
- Previous Close Price: 144.14
- Change: -1.14%
- Total Traded Volume: 2,022
- Total Buy Quantity: 37,190
- Total Sell Quantity: 23,677
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 142.00 | 10,000.00 | 0.00 |
| 142.05 | 15.00 | 0.00 |
| 142.12 | 7.00 | 0.00 |
| 142.20 | 45.00 | 0.00 |
| 143.00 | 1,230.00 | 0.00 |
| 144.10 | 0.00 | 200.00 |
| 144.14 | 0.00 | 3,469.00 |
| 144.90 | 0.00 | 616.00 |
| 144.99 | 0.00 | 255.00 |
| 145.95 | 0.00 | 40.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 151.33 | 200 | 151.46 | 111 |
| 151.30 | 36 | 151.47 | 109 |
| 151.26 | 35 | 151.48 | 271 |
| 151.25 | 1,090 | 151.49 | 297 |
| 151.21 | 85 | 151.50 | 890 |
Total Buy Quantity: 37190
Total Sell Quantity: 23677
Shareholding Patterns of Camlin Fine Sciences Limited
Key Trade Statistics of Camlin Fine Sciences Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 4.95 |
| Traded Value (₹ Cr.) | 7.32 |
| Total Market Cap (₹ Cr.) | 2,843.43 |
| Free Float Market Cap (₹ Cr.) | 1,386.81 |
| Impact cost | 0.1 |
| Quantity Traded | 1,534,067.00 |
| Deliverable Quantity | 436,012.00 |
| % of Quantity to Traded | 28.42 |
| Security VaR | 19.76 |
| Index VaR | N/A |
| VaR Margin | 19.76 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 23.26 |
| Face Value | 1 |
Key Price Statistics of Camlin Fine Sciences Limited
The 52-week high for Camlin Fine Sciences Limited was ₹165.19, recorded on 25-Feb-2025. On the other hand, the 52-week low stands at ₹78.38, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹172.96, and the lower band is ₹115.31. The price band is 20%.
The stock's daily volatility stands at 3.01, while the annualized volatility is 57.51. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (25-Feb-2025) | 165.19 |
| 52 Week Low (04-Jun-2024) | 78.38 |
| Upper Band | 172.96 |
| Lower Band | 115.31 |
| Price Band (%) | 20 |
| Daily Volatility | 3.01 |
| Annualised Volatility | 57.51 |
| Tick Size | 0.01 |
Key Securities Statistics of Camlin Fine Sciences Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 20-Jan-2015 |
| Adjusted P/E | 0 |
| Symbol P/E | 0 |
| Index | NA |
| Macro-Economic Sector | Commodities |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Basic Industry | Specialty Chemicals |
Security Status of Camlin Fine Sciences Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Camlin Fine Sciences Limited
| Subject | Date |
|---|---|
| Updates | 25-Feb-2025 |
| Acquisition-XBRL | 25-Feb-2025 |
| Agreements | 24-Feb-2025 |
| Acquisition | 24-Feb-2025 |
| Investor Presentation | 19-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 17-Feb-2025 |
| Copy of Newspaper Publication | 17-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 14-Feb-2025 |
Corporate Actions of Camlin Fine Sciences Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 1 | Rights 5:41 @ Premium Rs 109/- | 08-Jan-2025 |
| 1 | Annual General Meeting | 24-Jul-2024 |
| 1 | Annual General Meeting | 24-Jul-2023 |
| 1 | Annual General Meeting | 21-Jul-2022 |
| 1 | Annual General Meeting | 12-Jul-2021 |
| 1 | Annual General Meeting | 31-Jul-2020 |
| 1 | Annual General Meeting | 25-Jul-2019 |
| 1 | Annual General Meeting | 03-Aug-2018 |
| 1 | Annual General Meeting | 13-Jul-2017 |
| 1 | Annual General Meeting/ Dividend - Re 0.45/- Per Share | 28-Jul-2016 |
| 1 | Annual General Meeting/Dividend - Re 0.45/- Per Share | 27-Jul-2015 |
Board Meetings of Camlin Fine Sciences Limited
Financial Results of Camlin Fine Sciences Limited
Company Directory of Camlin Fine Sciences Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | Floor 2 to 5 Building in G S Point Plot No VIII Private Layout Scheme Opp University Campus C S T Road Kalina Santacruz East |
MUMBAI |
| N/A | Registered Office | Floor 2 to 5 Building in G S Point Plot No VIII Private Layout Scheme Opp University Campus C S T Road Kalina Santacruz East |
MUMBAI |
| N/A | Transfer Agent | M/s. Link Intime India Pvt. Ltd. C101, 247 Park, LBS Marg, Vikhroli West, |
MUMBAI |
Insider Trading of Camlin Fine Sciences Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Ashish S.Dandekar | 0 | Buy |
| 7(2) | Anagha S. Dandekar | 0 | Buy |
| 7(2) | INFINITY HOLDINGS | 68084928 | Sell |
| 7(2) | Infinity Direct Holdings | 137515985 | Sell |
| 7(2) | Anfima NV | 225377000 | Buy |
| 7(2) | Ashish S Dandekar | 225377000 | Sell |
| 7(2) | Ashish S Dandekar | 100400000 | Pledge |
| 7(2) | Infinity Direct Holdings | 286278300 | Sell |
| 7(2) | Ashish S Dandekar | 546334470 | Buy |
| 7(2) | Ashish S Dandekar | 1057500000 | Pledge |
| 7(2) | Nirmal Vinod Momaya | 55767060 | Pledge |
| 7(2) | Sameer Arun Thakur | 2070900 | Sell |
| 7(2) | Rahul Dilip Dandekar | 14192010 | Sell |
| 7(2) | Arjun S Dukane | 1001988 | Sell |
| 7(2) | ASHISH S DANDEKAR | 0 | Pledge Revoke |
| 7(3) | INFINITY HOLDINGS | 37218433 | Buy |
| 7(2) | ASHISH S DANDEKAR | 309096000 | Pledge |
| 7(2) | Anagha S. Dandekar | 123327 | Buy |
| 7(2) | Anagha S. Dandekar | 1490989 | Buy |
| 7(2) | Anagha S. Dandekar | 2980813 | Buy |
Annual Reports of Camlin Fine Sciences Limited
Investor Complaints of Camlin Fine Sciences Limited
Event Calendar of Camlin Fine Sciences Limited
| Purpose | Details |
|---|---|
| Results | Inter-alia consider, take on record and approve the Unaudited Financial Results for the Quarter Ended December 31, 2014 pursuant to Clause 41 of the Listing Agreement. |
| Results/Dividend | inter- alia, to consider and take on record and approve the Audited Financial Results of the Company for the Financial Year Ended March 31st, 2015 and to consider recommendation of dividend on Equity Shares, if any thereon. |
| Results | inter-alia consider, take on record and approve the Unaudited Financial Results for the Quarter Ended June 30, 2015. |
| Results | inter- alia, to consider and take on record and approve the Un-audited Financial Results of the Company for the Second Quarter ended September 30, 2015. |
| Results | Inter- alia, to consider and take on record and approve the Un-audited Financial Results of the Company for the Third Quarter ended December 31, 2015. |
| Results/Dividend | Inter- alia, to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and financial year ended on March 31, 2016 and to consider and recommend dividend, if any, on the Equity Shares of the Company for the financial year 2015-16. |
| Qualified Institutional Placement | inter alia consider the following resolutions:(a). To approve the closure of the QIP;(b). To approve the issue price including a discount, if any thereto as permitted under the SEBI ICDR Regulations for the Equity Shares to be allotted to qualified institutional buyers pursuant to the QIP; and(c). To approve and adopt the placement document in connection with the QIP. |
| Results | inter-alia, to consider and approve Unaudited Financial Results for the Second Quarter ended on September 30, 2016. |
| Results | To, inter-alia consider, take on record and approve the standalone and consolidated unaudited financial results for the quarter ended December 31, 2016. |
| Results/Dividend | Inter- alia, to consider and approve the Following Audited financial results (Standalone and Consolidated)for the quarter and financial year ended on March 31, 2017. To consider and recommend dividend, if any, on the Equity Shares of the Company for the financial year 2016-17. To raise funds not exceeding Rs. 250.00 Crores by way of QIP/GDR/ADR/FCCB/other securities linked to equity / preference shares / any instrument or securities representing convertible securities, subject to approval of shareholders. |
| Results | Inter-alia, to consider and approve Unaudited Financial Results for the First Quarter ended on June 30, 2017. |
| Results | Inter- alia, to consider and approve Unaudited Financial Results for the Second Quarter ended on September 30, 2017. |
| Preferential issue | inter alia to consider and approve raising funds through preferential allotment or otherwise. |
| Results | inter-alia consider, take on record and approve the standalone and consolidated unaudited financial results for the quarter ended December 31, 2017. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results/Fund Raising/Other business matters | To consider and approve the financial results for the period ended March 31, 2018, Fund Raising and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2018 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
| Financial results | Camlin Fine Sciences Limited has informed the Exchange about Board Meeting to be held on 12-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Fund Raising/Other business matters | To consider and approve the proposal for raising of funds by way of rights issue of equity shares under applicable laws or issue of any other securities of the Company. |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Fund Raising | To consider and approve the revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crores; and Issue of any debt securities of the Company. |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Camlin Fine Sciences Limited
Voting Results of Camlin Fine Sciences Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 18-OCT-2024 | Postal Ballot | Increase in Authorised Share Capital and Consequent Amendment to Clause V of the Memorandum of Association of the Company. |
| 31-JUL-2024 | AGM | To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2024 and the reports of the Board of Directors and Auditors thereon; and (b) the audited consolidated financial statement of the Company for the financial year ended March 31, 2024 and the report of the Auditors thereon. |
| 31-JUL-2024 | AGM | To re-appoint Mr. Amol Shah (DIN: 00171006) as an Independent Non-Executive Director of the Company, not liable to retire by rotation, to hold office for a further term of 5 (five) consecutive years commencing from August 2, 2024. |
| 31-JUL-2024 | AGM | To re-appoint Mr. Arjun Dukane (DIN: 06820240) as Executive Director ￢ﾀﾓ Technical of the Company for a further period of 3 (three) years with effect from June 1, 2024. |
| 31-JUL-2024 | AGM | To re-appoint Mr. Nirmal Momaya (DIN: 01641934) as Managing Director of the Company, not liable to retire by rotation, for a further period of 3 (three) years with effect from June 1, 2024. |
| 31-JUL-2024 | AGM | To re-appoint Mr. Ashish Dandekar (DIN: 01077379) as Chairman & Managing Director of the Company not liable to retire by rotation, for further period of 3 (three) years with effect from August 1, 2024. |
| 31-JUL-2024 | AGM | To ratify the remuneration of the Cost Auditor for the financial year ending March 31, 2025. |
| 31-JUL-2024 | AGM | Re-appointment of Mr. Harsha Raghavan (DIN: 01761512), who retires by rotation as a Non-Executive Director. |
| 31-JUL-2024 | AGM | Re-appointment of Ms. Anagha Dandekar (DIN: 07897205), who retires by rotation as a Non-Executive Director. |
| 31-JUL-2023 | AGM | To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2023 and the reports of the Board of Directors |
| 31-JUL-2023 | AGM | To ratify the remuneration of the Cost Auditor for the financial year ending March 31, 2024 |
| 31-JUL-2023 | AGM | Re-appointment of Ms. Anagha Dandekar (DIN: 07897205), who retires by rotation as a Non-Executive Director. |
| 31-JUL-2023 | AGM | Re-appointment of Mr. Arjun Dukane (DIN: 06820240), who retires by rotation as a Executive Director- Technical. |
| 29-JUL-2022 | AGM | To consider and adopt (a) the audited financial statements of the Company for the financial year ended March 31, 2022 and the reports of the Board of Directors and Auditors thereon; and (b) the audited consolidated financial statements of the Company for the financial year ended March 31, 2022 and the report of the Auditors thereon. |
| 29-JUL-2022 | AGM | To ratify the remuneration of M/s. ABK & Associates, Cost Auditor for the financial year ending March 31, 2023. |
| 29-JUL-2022 | AGM | To re-appoint M/s. Kalyaniwalla & Mistry LLP, Chartered Accountants (Firm Registration No. 104607W/ W100166), as Statutory Auditors |
| 29-JUL-2022 | AGM | To appoint a Director Mr. Harsha Raghavan (DIN: 01761512), who retires by rotation as a Non-Executive Director. |
| 29-JUL-2022 | AGM | To appoint a Director Mr. Arjun Dukane (DIN: 06820240), who retires by rotation as a Executive Director- Technical. |
| 26-MAR-2022 | Postal Ballot | Appointment of Mr. Pradip Kanakia (DIN: 00770347) as an Independent Non-Executive Director. |
| 20-JUL-2021 | AGM | Adoption of audited financial statement including consolidated financial statement of the Company for the year ended 31st March, 2021, the reports of the Board of Directors and the Auditors thereon. |
FAQs on Camlin Fine Sciences Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.